HRNR and cancer: Moreover, perturbed expression of hornerin possibly provides a starting point for the emergence of DDA-resistant cancer cells due to cancer-specific DDR defects, as depletion of hornerin substantially increased the survival rate of etoposide-treated cells (Fig. 8A, C).